Clinical Trial Update: Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for relapsed ovarian epithelial cancer, which is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: UNICANCER | Conditions: Ovarian Epithelial Cancer Recurrent | Phase 3 | Status: ACTIVE_NOT_RECRUITING